Pivotal trial launches of GRPR-targeted PET imaging agent in prostate cancer
Pivotal trial launches of GRPR-targeted PET imaging agent in prostate cancer Urology Times
Pivotal trial launches of GRPR-targeted PET imaging agent in prostate cancer Urology Times
Hinson highlights support for bills to support rural cancer treatment, research in rural Iowa Ottumwa Courier
Metastasis, the process by which a tumor spreads throughout the body, is associated with the majority of cancer deaths. The Brain Metastasis Group at the Spanish National Cancer Research Centre (CNIO) has investigated the earliest stages in which metastatic cells establish themselves in distant organs and discovered a…
Patients preparing for pancreatic cancer surgery maintained better physical function and experienced less fatigue with five treatments of stereotactic body radiation therapy (SBRT) than with 28 treatments of conventional radiation therapy given with chemotherapy, according to a randomized Phase II clinical trial.
Fractionated radiosurgery reduces cancer recurrence after surgery for large brain metastases, trial finds Medical Xpress
Patients with small cell lung cancer (SCLC) that had spread to the brain lived a median of 17 months after focused stereotactic radiosurgery, compared with nine months after an advanced form of whole-brain radiation therapy, an unexpected secondary finding from the first randomized Phase III trial to compare the…
Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in the first randomized trial to directly compare the treatments for localized prostate cancer.
Delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced the risk of cancer returning at the surgical site compared with delivering the radiation in a single session, according to the first randomized Phase III clinical trial directly comparing the approaches.
Flavio Rocha: Excited to Be Part of This Team to Transform OHSU Knight Cancer Institute Oncodaily
Phase III Trial Compares HER2-Directed Antibody-Drug Conjugates in Advanced Breast Cancer The ASCO Post
Ранний осмотр — шанс на жизнь: как в Юргинской больнице спасают женщин от онкологии МегаТюмень
Windsor Regional Hospital, University of Windsor benefit from research funding for precision oncology Windsor News Today
Windsor Regional Hospital, University of Windsor benefit from research funding for precision oncology CKNX News Today
B7-H3 Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by Expanding Cancer Therapeutics Pipeline | DelveInsight PR Newswire